Skip to content

Clinical trials

Phase 4 Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 4 Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20024
20033
20041
20058
20067
20077
20089
20098
201010
201116
20128
201310
20146
20155
20164
20171
20181
20192
20202
20212
20222
20231
20241
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99
Terminated7
Unknown status7
Recruiting6
Withdrawn4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research37
Allergan21
Glaukos Corporation6
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
Pharmaceutical Research Network4
Aristotle University Of Thessaloniki2
Bp Consulting, Inc2
Laboratorios Poen2
Aerie Pharmaceuticals1
Alcon, a Novartis Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension125
Glaucoma, Open-Angle86
Glaucoma63
Eye Diseases7
Hypertension2
Low Tension Glaucoma2
Cardiovascular Diseases1
Dry Eye Syndromes1
Exfoliation Syndrome1
Fibrosis1

Trials

Showing 51 to 75 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.